Cambridge Cognition Holdings To host a Capital Markets Showcase via Webex

Cambridge Cognition
[shareaholic app="share_buttons" id_name="post_below_content"]

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it will be hosting a Capital Markets Showcase via Webex on 30th June 2020 at 10am.

The event will feature a series of presentations from Cambridge Cognition’s management and senior leadership team focussing on the latest developments in the Company’s product and technology portfolios.

To express interest in attending the event please email: [email protected]

No material new information or update on current trading will be disclosed at the event.

Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Cambridge Cognition Holdings plc announces the formation of a Scientific Advisory Board to guide brain health strategies and market trends effectively.
Cambridge Cognition Holdings plc partners with ActiGraph to enhance brain health assessments in clinical trials, aiming to improve treatments for CNS disorders.
Cambridge Cognition Holdings plc has announced the appointment of Stuart Gall and Philip Rodgers as independent non-executive Directors, to support the company's growth plans in the healthcare and technology sectors.

Search

Search